Recombinant IL17A (Secukinumab Biosimilar) anticorps
Research Grade
Reactivité: Humain
ELISA
Hôte: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
- Antigène Tous les produits IL17A (Secukinumab Biosimilar)
- IL17A (Secukinumab Biosimilar)
- Type d'anticorp
- Recombinant Antibody
- Reactivité
- Humain
-
Hôte
-
Mammalian Cells
- Expression System
- Mammalian cells
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp IL17A (Secukinumab Biosimilar) est non-conjugé
- Application
- ELISA
- Fonction
- Secukinumab Biosimilar - Anti-IL17A mAb
- Attributs du produit
- Antibody Type: IgG1-kappa
- Purification
- Recombinant antibody expressed in mammalien cells and purified.
- Classe de qualité
- Research Grade
- Isotype
- IgG1 kappa
-
-
- Restrictions
- For Research Use only
-
- Buffer
- PBS pH 7.5
- Stock
- -80 °C
- Stockage commentaire
- store at -80°C
-
- Antigène
- IL17A (Secukinumab Biosimilar)
- Abstract
- IL17A (Secukinumab Biosimilar) Produits
- Classe de substances
- Biosimilar
- Sujet
-
AIN457
Secukinumab is a fully human monoclonal immunoglobulin G1κ antibody targeting human interleukin-17A( IL-17A ). IL-17A is a naturally occurring cytokine that is involved in normal inflammatory and immune responses.
-
Vous êtes ici:
